Validating LENT score in malignant pleural effusion.

Autor:	Alawneh A; Jordan University of Science & Technology, Faculty of Medicine, Internal Medicine Department, 3030, Ar-Ramtha, Jordan., Farsakh FA; King Hussein Cancer Center, Palliative Medicine Department, Queen Rania St 202, Amman, Jordan., Smadi M; Jordan University of Science & Technology, Faculty of Science, Mathematics Department, 3030, Ar-Ramtha, Jordan., Samrah S; Jordan University of Science & Technology, Faculty of Medicine, Internal Medicine Department, Pulmonary & Critical Care Division, 3030, Ar-Ramtha, Jordan.
Jazyk:	angličtina
Zdroj:	Future science OA [Future Sci OA] 2024 May 20; Vol. 10 (1), pp. FSO958. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
DOI:	10.2144/fsoa-2023-0168
Abstrakt:	Aim: LENT score was developed to predict survival in malignant pleural effusion (MPE), this study aims to validate this score. Objectives: Validate LENT Prognostic Score for MPE and explore survival in these patients. Methods: Retrospective analysis of 202 patients who had MPE and received drainage between January 2013 and June 2015. Results: Median survival was 2.98 months. Patients were classified according to LENT score as low, moderate and high-risk groups: 5 (4.2%), 61 (50.8%), and 54 (45%), respectively. Kaplan-Meier curve showed median survival for each group: 9.41, 5.36 and 0.56 months, respectively, p-values <0.001. AUC for 1, 3 and 6 months: 0.741, 0.781, 0.790, respectively, p-values <0.001. Conclusion: LENT score is valid for predicting survival in patients with MPE. Competing Interests: The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. (© 2024 Jordan University of Science and Technology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu